3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-vinylpyridine

Catalog No.: 
ACWSTX095
CAS No.: 
2762661-51-6
Molecular Formula: 
C13H18BNO2
Molecular Weight: 
231.10
3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-vinylpyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$492.00InquiryInquiry
1g95%$1562.00InquiryInquiry
5g95%$4686.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-vinylpyridine
IUPAC Name3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-vinylpyridine
Molecular FormulaC13H18BNO2
Molecular Weight231.10
SMILESCC1(C)C(C)(C)OB(C2=CC=CN=C2C=C)O1
InChI KeyPAIYBURLXVQODN-UHFFFAOYSA-N
Synonym2-ethenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-vinylpyridine
CAS No.2762661-51-6

Synthetic Route by SureRoute

1. ACWSTX095 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPWGJ827 route compound structure diagram
    ACPWGJ827452972-11-1In Stock
  4. Then
  5. ACWSTX095 route product structure diagram
    ACWSTX0952762661-51-6
Inquiry

2. ACWSTX095 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPWGJ827 route compound structure diagram
    ACPWGJ827452972-11-1In Stock
  4. Then
  5. ACWSTX095 route product structure diagram
    ACWSTX0952762661-51-6
Inquiry

3. ACWSTX095 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACANMZ368 route compound structure diagram
    ACANMZ368799246-56-3In Stock
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3In Stock
  4. Then
  5. ACWSTX095 route product structure diagram
    ACWSTX0952762661-51-6
Inquiry

Comments (0)